Tendee LogoChatBlog
Public Tender Opportunity

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA]

Published on October 21, 2025

Tender Description

OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA]

Unlock Full Tender Insight

Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.

It's free to get started. No credit card required.

Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA] | Public Tender | tend.ee